GMPLEX™ has a network of contract manufacturing organisations in various geographies to manufacture diverse dosage forms in addition to what can be manufactured in-house. This gives our partners breadth of supply and resilience, whatever the therapeutic area.

In-house manufacturing modules cover core forms, while our partner network extends the portfolio without compromising quality oversight.
Immediate and modified release tablets, hard and soft capsules, produced in GMP manufacturing modules with full in-process control.
Syrups, solutions and suspensions filled under controlled conditions, with stability programmes supporting Australian and export markets.
Topical dosage forms manufactured and filled to specification, with validated cleaning between campaigns.
Cold room and controlled-temperature storage with monitored distribution for products that cannot tolerate excursions.
Regulated primary and secondary packaging, serialisation-ready lines and artwork control aligned to TGA requirements.
A network of contract manufacturing organisations across multiple geographies extends the range beyond what is made in-house.